Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 653

1.

Current Concepts and Controversies in Innate Immunity of Cystic Fibrosis Lung Disease.

Ralhan A, Laval J, Lelis F, Ballbach M, Grund C, Hector A, Hartl D.

J Innate Immun. 2016 Jul 1. [Epub ahead of print]

PMID:
27362371
2.

Neighboring genes for DNA-binding proteins rescue male sterility in Drosophila hybrids.

Liénard MA, Araripe LO, Hartl DL.

Proc Natl Acad Sci U S A. 2016 Jun 29. pii: 201608337. [Epub ahead of print]

PMID:
27357670
3.

Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.

Ballbach M, Hall T, Brand A, Neri D, Singh A, Schaefer I, Herrmann E, Hansmann S, Handgretinger R, Kuemmerle-Deschner J, Hartl D, Rieber N.

J Innate Immun. 2016 Jun 29. [Epub ahead of print]

PMID:
27351923
4.

Intraoperative Near-infrared Imaging for Parathyroid Gland Identification by Auto-fluorescence: A Feasibility Study.

De Leeuw F, Breuskin I, Abbaci M, Casiraghi O, Mirghani H, Ben Lakhdar A, Laplace-Builhé C, Hartl D.

World J Surg. 2016 May 24. [Epub ahead of print]

PMID:
27220510
5.

CHI3L1 polymorphisms, cord blood YKL-40 levels and later asthma development.

Usemann J, Frey U, Mack I, Schmidt A, Gorlanova O, Röösli M, Hartl D, Latzin P.

BMC Pulm Med. 2016 May 18;16(1):81. doi: 10.1186/s12890-016-0239-8.

6.

Immune Mechanisms in Pulmonary Fibrosis.

Kolahian S, Fernandez IE, Eickelberg O, Hartl D.

Am J Respir Cell Mol Biol. 2016 May 5. [Epub ahead of print]

PMID:
27149613
7.

mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo.

Zeyer F, Mothes B, Will C, Carevic M, Rottenberger J, Nürnberg B, Hartl D, Handgretinger R, Beer-Hammer S, Kormann MS.

PLoS One. 2016 Apr 21;11(4):e0154001. doi: 10.1371/journal.pone.0154001. eCollection 2016.

8.

Anti-angiogenic Tyrosine Kinase Inhibitors: occurrence and risk factors of hemoptysis in refractory thyroid cancer.

Lamartina L, Ippolito S, Danis M, Bidault F, Borget I, Berdelou A, Al Ghuzlan A, Hartl D, Blanchard P, Terroir M, Deandreis D, Schlumberger M, Baudin E, Leboulleux S.

J Clin Endocrinol Metab. 2016 Apr 15:jc20154391. [Epub ahead of print]

PMID:
27082933
9.

Anatomic Variability of the Upper Mediastinal Lymph Node Level VII.

Hartl DM, Breuskin I, Mirghani H, Berdelou A, Déandréis D, Pottier E, Borget I, Schlumberger M, Leboulleux S.

World J Surg. 2016 Apr 13. [Epub ahead of print]

PMID:
27075985
10.

Myeloid-Derived Suppressor Cells in Bacterial Infections.

Ost M, Singh A, Peschel A, Mehling R, Rieber N, Hartl D.

Front Cell Infect Microbiol. 2016 Mar 31;6:37. doi: 10.3389/fcimb.2016.00037. eCollection 2016. Review.

11.

Chitinase activation in patients with fungus-associated cystic fibrosis lung disease.

Hector A, Chotirmall SH, Lavelle GM, Mirković B, Horan D, Eichler L, Mezger M, Singh A, Ralhan A, Berenbrinker S, Mack I, Ensenauer R, Riethmüller J, Graepler-Mainka U, Murray MA, Griese M, McElvaney NG, Hartl D.

J Allergy Clin Immunol. 2016 Apr 4. pii: S0091-6749(16)00303-1. doi: 10.1016/j.jaci.2016.01.031. [Epub ahead of print]

PMID:
27056270
12.

SORLA regulates calpain-dependent degradation of synapsin.

Hartl D, Nebrich G, Klein O, Stephanowitz H, Krause E, Rohe M.

Alzheimers Dement. 2016 Mar 25. pii: S1552-5260(16)00083-2. doi: 10.1016/j.jalz.2016.02.008. [Epub ahead of print]

PMID:
27021222
13.

CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.

Carevic M, Öz H, Fuchs K, Laval J, Schroth C, Frey N, Hector A, Bilich T, Haug M, Schmidt A, Autenrieth SE, Bucher K, Beer-Hammer S, Gaggar A, Kneilling M, Benarafa C, Gao JL, Murphy PM, Schwarz S, Moepps B, Hartl D.

J Innate Immun. 2016;8(4):362-73. doi: 10.1159/000444125. Epub 2016 Mar 8.

PMID:
26950764
14.

Biophysical principles predict fitness landscapes of drug resistance.

Rodrigues JV, Bershtein S, Li A, Lozovsky ER, Hartl DL, Shakhnovich EI.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1470-8. doi: 10.1073/pnas.1601441113. Epub 2016 Feb 29. Erratum in: Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1964.

PMID:
26929328
15.

Increased risk of interstitial lung disease in children with a single R288K variant of ABCA3.

Wittmann T, Frixel S, Höppner S, Schindlbeck U, Schams A, Kappler MV, Hegermann J, Wrede C, Liebisch G, Vierzig A, Zacharasiewicz A, Kopp M, Poets CF, Baden W, Hartl D, Van Kaam AH, Lohse P, Aslanidis C, Zarbock R, Griese M.

Mol Med. 2016 Feb 26. doi: 10.2119/molmed.2015.00244. [Epub ahead of print]

PMID:
26928390
16.

Update on host-pathogen interactions in cystic fibrosis lung disease.

Hector A, Frey N, Hartl D.

Mol Cell Pediatr. 2016 Dec;3(1):12. doi: 10.1186/s40348-016-0039-5. Epub 2016 Feb 23.

17.

Microbial colonization and lung function in adolescents with cystic fibrosis.

Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D.

J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5.

PMID:
26856310
18.

Neutrophils in cystic fibrosis.

Laval J, Ralhan A, Hartl D.

Biol Chem. 2016 Jun 1;397(6):485-96. doi: 10.1515/hsz-2015-0271.

PMID:
26854289
19.

The emerging role of myeloid-derived suppressor cells in lung diseases.

Kolahian S, Öz HH, Zhou B, Griessinger CM, Rieber N, Hartl D.

Eur Respir J. 2016 Mar;47(3):967-77. doi: 10.1183/13993003.01572-2015. Epub 2016 Feb 4.

PMID:
26846830
20.

A pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivax.

Ogbunugafor CB, Hartl D.

Malar J. 2016 Jan 25;15:40. doi: 10.1186/s12936-016-1090-3.

Items per page

Supplemental Content

Write to the Help Desk